The global spread of clinical trials

David Skuse

doi:10.1192/S1749367600003027

The global spread of clinical trials

Published online by Cambridge University Press: 02 January 2018

David Skuse

Show author details

David Skuse*: Affiliation:
Behavioural and Brain Sciences Unit, Institute of Child Health, London, UK, email [email protected]

Article contents

Extract
References

Rights & Permissions

Extract

Core share and HTML view are not available for this content. However, as you have access to this content, a full PDF is available via the ‘Save PDF’ action button.

There has been considerable publicity recently in the UK concerning the threatened contraction of the country's pharmaceutical industry. The UK currently has the third highest share of global pharmaceutical research and development expenditure (after the USA and Japan), but the costs of conducting research in the UK are rising.

Type: Thematic Papers
Information: International Psychiatry , Volume 9 , Issue 2 , May 2012 , pp. 29 - 30

DOI: https://doi.org/10.1192/S1749367600003027 [Opens in a new window]
Creative Commons: This is an Open Access article, distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivatives licence (http://creativecommons.org/licenses/by-nc-nd/4.0/), which permits noncommercial re-use, distribution, and reproduction in any medium, provided the original work is unaltered and is properly cited. The written permission of Cambridge University Press must be obtained for commercial re-use or in order to create a derivative work.